한빛사논문, 상위피인용논문
Abstract
Dong Ju Son1,2,*, Sandeep Kumar1,2,*, Wakako Takabe1,2, Chan Woo Kim1,2,3, Chih-Wen Ni1,
Noah Alberts-Grill2, In-Hwan Jang1, Sangok Kim4, Wankyu Kim4, Sang Won Kang4, Andrew H. Baker5,
Jai Woong Seo6, Katherine W. Ferrara6 & Hanjoong Jo1,2,3
1Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, Georgia 30322, USA. 2 Division of Cardiology, Department of Medicine, Emory University, Atlanta, Georgia 30322, USA. 3 Department of Bioinspired Science, Ewha Womans University, Seoul 120-750, South Korea. 4 Department of Life Science, Ewha Womans University, Seoul, South Korea. 5 Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 8TA, UK. 6 Department of Biomedical Engineering, University of California, Davis, California 95616, USA.
* These authors contributed equally to this work.
Correspondence and requests for materials should be addressed to H.J.
MicroRNAs (miRNAs) regulate cardiovascular biology and disease, but the role of flow-sensitive microRNAs in atherosclerosis is still unclear. Here we identify miRNA-712 (miR-712) as a mechanosensitive miRNA upregulated by disturbed flow (d-flow) in endothelial cells, in vitro and in vivo. We also show that miR-712 is derived from an unexpected source, pre-ribosomal RNA, in an exoribonuclease-dependent but DiGeorge syndrome critical region 8 (DGCR8)-independent manner, suggesting that it is an atypical miRNA. Mechanistically, d-flow-induced miR-712 downregulates tissue inhibitor of metalloproteinase 3 (TIMP3) expression, which in turn activates the downstream matrix metalloproteinases (MMPs) and a disintegrin and metalloproteases (ADAMs) and stimulate pro-atherogenic responses, endothelial inflammation and permeability. Furthermore, silencing miR-712 by anti-miR-712 rescues TIMP3 expression and prevents atherosclerosis in murine models of atherosclerosis. Finally, we report that human miR-205 shares the same ‘seed sequence’ as murine-specific miR-712 and also targets TIMP3 in a flow-dependent manner. Targeting these mechanosensitive ‘athero-miRs’ may provide a new treatment paradigm in atherosclerosis.
논문정보
관련 링크
연구자 키워드
소속기관 논문보기
관련분야 논문보기